NM_001440.4:c.1324G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001440.4(EXTL3):​c.1324G>C​(p.Val442Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00245 in 1,614,190 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 43 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 42 hom. )

Consequence

EXTL3
NM_001440.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.62

Publications

4 publications found
Variant links:
Genes affected
EXTL3 (HGNC:3518): (exostosin like glycosyltransferase 3) This gene encodes a single-pass membrane protein which functions as a glycosyltransferase. The encoded protein catalyzes the transfer of N-acetylglucosamine to glycosaminoglycan chains. This reaction is important in heparin and heparan sulfate synthesis. Alternative splicing results in the multiple transcript variants. [provided by RefSeq, Nov 2012]
EXTL3 Gene-Disease associations (from GenCC):
  • immunoskeletal dysplasia with neurodevelopmental abnormalities
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0037114024).
BP6
Variant 8-28717383-G-C is Benign according to our data. Variant chr8-28717383-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 446049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0124 (1889/152302) while in subpopulation AFR AF = 0.0424 (1761/41554). AF 95% confidence interval is 0.0407. There are 43 homozygotes in GnomAd4. There are 868 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 43 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EXTL3NM_001440.4 linkc.1324G>C p.Val442Leu missense_variant Exon 3 of 7 ENST00000220562.9 NP_001431.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EXTL3ENST00000220562.9 linkc.1324G>C p.Val442Leu missense_variant Exon 3 of 7 1 NM_001440.4 ENSP00000220562.4

Frequencies

GnomAD3 genomes
AF:
0.0124
AC:
1887
AN:
152184
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0425
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00556
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000220
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00336
AC:
844
AN:
251448
AF XY:
0.00230
show subpopulations
Gnomad AFR exome
AF:
0.0434
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.00308
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000229
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.00142
AC:
2073
AN:
1461888
Hom.:
42
Cov.:
33
AF XY:
0.00121
AC XY:
881
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0460
AC:
1541
AN:
33478
American (AMR)
AF:
0.00237
AC:
106
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00371
AC:
97
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.000123
AC:
137
AN:
1112012
Other (OTH)
AF:
0.00296
AC:
179
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
141
282
424
565
706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0124
AC:
1889
AN:
152302
Hom.:
43
Cov.:
32
AF XY:
0.0117
AC XY:
868
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0424
AC:
1761
AN:
41554
American (AMR)
AF:
0.00556
AC:
85
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000220
AC:
15
AN:
68028
Other (OTH)
AF:
0.00992
AC:
21
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
90
179
269
358
448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00229
Hom.:
6
Bravo
AF:
0.0143
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0411
AC:
181
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00404
AC:
491
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 27, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunoskeletal dysplasia with neurodevelopmental abnormalities Benign:1
May 18, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
7.0
DANN
Benign
0.67
DEOGEN2
Benign
0.34
T;T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.86
D;D
MetaRNN
Benign
0.0037
T;T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
0.74
.;N
PhyloP100
1.6
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.66
N;N
REVEL
Benign
0.25
Sift
Benign
0.51
T;T
Sift4G
Benign
0.73
T;T
Polyphen
0.0040
.;B
Vest4
0.14
MVP
0.69
MPC
0.31
ClinPred
0.0036
T
GERP RS
-0.76
Varity_R
0.042
gMVP
0.64
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116659770; hg19: chr8-28574900; API